abstract |
The present invention is a compound of formula I that functions as an inhibitor of BCL6 (B cell lymphoma 6) activity. (In the formula, X 1 , X 2 , R 1 , R 2 , R 30 , R 31 and ring A are each as defined herein). The present invention also relates to the processes for preparing these compounds and their use in the treatment of proliferative diseases such as cancer and other diseases or conditions associated with BCL6 activity with pharmaceutical compositions containing them. Regarding. |